Nom du produit:(E)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-2-bromoacrylic acid

IUPAC Name:(2E)-3-{3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}-2-bromoprop-2-enoic acid

CAS:1642300-94-4
Formule moléculaire:C13H6BrF6N3O2
Pureté:95%+
Numéro de catalogue:CM338456
Poids moléculaire:430.1

Unité d'emballage Stock disponible Prix($) Quantité
CM338456-100mg in stock ȦɐƱ
CM338456-250mg in stock ƋȌƱ
CM338456-1g in stock ƤƱƱ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1642300-94-4
Formule moléculaire:C13H6BrF6N3O2
Point de fusion:-
Code SMILES:O=C(O)/C(Br)=C\N1N=C(C2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2)N=C1
Densité:
Numéro de catalogue:CM338456
Poids moléculaire:430.1
Point d'ébullition:
N° Mdl:
Stockage:2-8°C

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.